Medication Adherence

Optimizing patient-provider communication and enhancing patient self-efficacy may improve medication adherence rates among patients with systemic lupus erythematosus, according to results presented at the ACR Convergence 2020 meeting.

Medication affordability is a major issue in the United States. CMS estimates U.S. prescription drug expenditure was $335 billion in 2018, and recent studies have shown that the cost of prescription drugs is surging faster than any other medical service or good.

The polypill approach to CVD prevention has demonstrated significant reduction in both BP and LDL levels but may fall short of addressing the larger underlying drivers of health disparities, a speaker reported.

Have you ever had one of those days? Or weeks? Heck, have you ever had one of those months where it seems as if none of your patients with dry eye disease are following the plan you both agreed o n 3 or 4 or 6 months ago? Of course you have.

The Glaucoma Treatment Compliance Assessment Tool is an efficient way to determine patient-specific factors that affect glaucoma therapy adherence, according to a study.

Polytherapy, especially the use of three or more antiepileptic drugs, correlated with a substantially decreased risk for sudden unexpected death in epilepsy, according to findings from a nationwide case-control study conducted in Sweden.

The risk for death significantly decreased in older patients who adhered to antihypertensive treatment, according to a study published in Hypertension.

In patients with glaucoma who reported never missing a single dose of medication over 8 years, the estimated loss of visual field was significantly less when compared with patients who reported missing doses, according to a study.

Patients with atrial fibrillation who received smartwatch notifications in addition to standard care had better adherence to oral anticoagulation compared with those who received standard care alone, according to data presented at the virtual Heart Rhythm Society Annual Scientific Sessions.

WASHINGTON — Patients who better adhered to topical glaucoma medications over time experienced a slower rate of visual field decline compared with patients with poor adherence to their medications, according to a speaker here.